NASDAQ : SENS

Senseonics Holdings, Inc. — Company profile

Healthcare · Medical Devices · United States

Last price 9.47 USD (Oct 30, 2026, 10:10 AM EDT) · Market cap 500.72M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Details

NameSenseonics Holdings, Inc.
SectorHealthcare
IndustryMedical Devices
Employees130
Founded1996
CeoTimothy Goodnow
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS81727U3032
Cusip81727U303
Cik0001616543
Sic3823
Stock TypeCommon Stock

Key executives

NameTitle
Dr. Timothy T. Goodnow Ph.D.President, Chief Executive Officer and Director
Frederick T. Sullivan CPAChief Financial Officer, Secretary and Treasurer
Dr. Mukul Jain Ph.D.Chief Operating Officer
Dr. Francine Ratner Kaufman M.D.Chief Medical Officer and Director
Brian B. HansenChief Commercial Officer and Director
Kenneth L. Horton J.D.General Counsel and Corporate Development Advisor

Contact

Address20451 Seneca Meadows Parkway, Germantown, Maryland 20876-7005, United States
Phone301 515 7260
Websitehttps://www.senseonics.com